Herbas VPB

Print
EN | LT
LT - COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
EN - COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/506
A61K 31/519
A61K 45/06
A61P 35/00
European patent
(11) Number of the document 3038652
(13) Kind of document T
(96) European patent application number 14766301.7
Date of filing the European patent application 2014-08-28
(97) Date of publication of the European application 2016-07-06
(45) Date of publication and mention of the grant of the patent 2018-03-21
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2014/053244
Date 2014-08-28
PCT application publication
(87) Number WO 2015/031666
Date 2015-03-05
Priority applications
(30) Number Date Country code
201361871275 P 2013-08-28 US
Inventors
(72)
HARRIS, Jennifer Leslie, US
LI, Nanxin, US
SMITH, Timothy R., US
Grantee
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Title
(54) COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
  COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES
Last update date 2021-04-30